Novel Dual CAR T Cell Immunotherapy Holds Promise for Targeting the HIV Reservoir

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.massgeneral.org/news/press-release/Novel-dual-car-t-cell-immunotherapy-holds-promise-for-targeting-the-hiv-reservoir
Research Institution
Massachusetts General Hospital
Short Title
Novel Dual CAR T Cell Immunotherapy Holds Promise Targeting HIV Reservoir
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

Beating HIV and COVID-19 May Depend on Tweaking Vaccine Molecules

Decreased Intubation, Reduced Mortality, Increased Discharge in Severe COVID-19 Patients When Administered Interleukin-6 Inhibitors Early

Link Type
Funded-research
Publish or Event Date
Link URL
https://www.bmc.org/news/press-releases/2020/08/04/decreased-intubation-reduced-mortality-increased-discharge-severe
Research Institution
Boston Medical Center
Short Title
Decreased Intubation Reduced Mortality Increased Discharge Severe COVID 19 Patients When Administered Interleukin-6 Inhibitors Early
Content Coordinator
Claudia Wair
Content Manager
Kathy Donbeck

Researchers Uncovered the Zika Virus Mutation Responsible for Quick Spread, Birth Defects

New Published Study from K-State Virologists Identifies Potential COVID-19 Treatment

How To Work With the Integrated Research Facility at Fort Detrick

About the Integrated Research Facility at Fort Detrick

Background and Purpose

The Integrated Research Facility at Fort Detrick (IRF-Frederick) is situated within the National Interagency Confederation for Biomedical Research (NICBR), a group of federal biomedical research facilities located on the National Interagency Biodefense Campus (NIBC) at Fort Detrick, in Frederick, Maryland.

COVID-19 Research at the Integrated Research Facility at Fort Detrick

The Integrated Research Facility at Fort Detrick (IRF-Frederick) team has extensive experience in testing potential medical countermeasures for high-consequence viral pathogens. Leveraging this experience, scientists at the IRF-Frederick have developed and are using cell‑based in vitro assays and animal models to test potential therapeutics for and vaccines against COVID‑19. The unique medical imaging capabilities of the IRF-Frederick are also being used to understand pathological consequences of SARS‑CoV‑2 in relevant animal models of disease.

A Cure for Herpes? There is Progress to Report

Cryo-EM Study Yields New Clues to Chicken Pox Infection

Subscribe to